Yolk Sac Tumor

11 registered clinical trials studyying Yolk Sac Tumor — 6 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Cytokine Armored GPC3 Specific Chimeric Antigen Receptor Expressing T-cells in Adults With Solid Tumors NCT07224568	Seattle Children's Hospital	Phase 1
Recruiting	Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-speci NCT07148050	Seattle Children's Hospital	Phase 1
Recruiting	Immunotherapy For Adults With GPC3-Positive Solid Tumors Using IL-15 and IL-21 Armored GPC3-CAR T Cells NCT06198296	Baylor College of Medicine	Phase 1
Recruiting	Agnostic Therapy in Rare Solid Tumors NCT06638931	Instituto do Cancer do Estado de São Paulo	Phase 2
Recruiting	Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatri NCT04715191	Baylor College of Medicine	Phase 1
Recruiting	Molecular Epidemiology of Pediatric Germ Cell Tumors NCT05564026	Children's Oncology Group	—
Completed	Thalidomide Combined With Chemotherapy in the Treatment of Relapsed or Refractory Yolk Sac Tumor NCT06470464	Shandong First Medical University	Phase 2
Active Not Recruiting	Interleukin-15 Armored Glypican 3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid NCT04377932	Baylor College of Medicine	Phase 1
Active Not Recruiting	Interleukin-15 Armored Glypican 3-specific Chimeric Antigen Receptor Expressed in Autologous T Cells for Solid NCT05103631	Baylor College of Medicine	Phase 1
Completed	Clinical Study of Chemotherapy in the Treatment of Recurrent/Refractory Yolk Sac Tumor in Children NCT06341998	Shandong First Medical University	Phase 2 / Phase 3
Active Not Recruiting	Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treat NCT02375204	Alliance for Clinical Trials in Oncology	Phase 3